Havana, May 5 (RHC-PL)-- Experts from 24 countries will gather in Havana to discuss leukemia, immunology, coagulation problems and others, during the 8th Cuban Congress of Hematology (Hematology 2017), beginning May 8th in the Cuban capital.

For the first time, the American Association of Hematology (ASH) will be present at this event, bringing several papers for discussion.

The 8th Congress will be a platform for Cuba to present its achievements in the field of hematology, the result of the investment by the government in new technologies for the treatment and diagnosis of pathologies, said Doctor Consuelo Macias, vice-president of the Organizing Committee.

Dr. Macias added that Cuba has an 80 percent success rate in treatments for acute lymphoblastic leukemia and more than 90 percent in other variants of the disease.

The 8th Congress will concentrate on malignant hemopathies, coagulation disorders, immunodeficiencies and other topics.

The event will host the 5th International Workshop of Hemophilia and Other Coagulation Disorders, and the Workshop for Primary Immunodeficiency. In parallel to this the 10th Latin American Day for Hamatology, Immunology and Transfusional Medicine, will take place.

Hematology 2017 will be in session until May 12th at Havana's Convention Center, and will have lectures by experts from Germany, Angola, Brazil, Canada, Costa Rica, the United States, Mexico, Nicaragua, Panama, Peru, United Kingdom, Switzerland, Turkey and Venezuela.

This event began in Cuba in 1973 and now is held every 4 years in the Cuban capital.